Tak-242 ameliorates hepatic fibrosis by regulating the liver- gut axis

HIGHLIGHTS

• who: Sujie Liu and collaborators from the Graduate School of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China have published the paper: TAK-242 Ameliorates Hepatic Fibrosis by Regulating the Liver- Gut Axis, in the Journal: BioMed Research International of 16/08/2022
• what: The aims of this study were to investigate the impact of TAK-242 on the Toll-like receptor 4 (TLR4)/myeloid differentiation factor 88 (MyD88)/nuclear transcription factor-κB (NF-κB) signal transduction pathway in rats with hepatic fibrosis (HF) using the liver gut axis and to investigate the molecular mechanism . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.